In addition, there were no differences in AMH, T, LH, or number of endocrinopathies in those who required a re-do operation compared to those who did not, although basal FSH was higher in those who did require a re-do (1.6 U/L vs 0.9 U/L, P = .02) (Fig. 4) and a genetic variant was not more likely to predict the need for a re-do operation. The gene discussed is PLOD1; the disease is endocrine system disorder.